Skip to main content

Table 1 Summary of found epitopes from the study from LTNP sera

From: Identifiable biomarker and treatment development using HIV-1 long term non-progressor sera

Epitope

Epitope sequence

Location in gp160

Sequence match

A

QARLLLSGIVQQQMNLLRAT

Start: AA 541

100% identical (100 out of 100)

End: AA 560

B

GCSGKLICTTTVPWNASWSNKSL

Start: AA 598

95.7-100% identical (20 of 100, 100%; 75 of 100, 95.7%); core epitope KLIC is 100%

End: AA 620

C

LLELDKWASLWNWFDITNWLW

Start: AA 661

100% identical (100 out of 100)

End: AA 681

D

DITNWLWYIKI

Start: AA 675

100% identical (100 out of 100)

End: AA 685

E

WYIKIFIMIVGGLVGLRIVF

Start: AA 681

90-100% identical (3 of 100, 90%; 82 of 100, 95%; 15 of 100, 100%)

End: AA 700

F

PEGIEEEGGERDRDTRGRLV

Start: AA 731

85-100% identical (8 of 100, 85%; 92 of 100, 100%)

End: AA 750

G

IWVDLRSLFLFSYH

Start: AA 757

92.9-100% identical (2 of 100, 92.9%; 98 of 100, 100%)

End: AA 770

CL3

GCSGKLICTT

Start: AA 598

100% identical (100 out of 100)

End: AA 607

  1. 5 LTNP patients were assayed for 7 different epitopes and CL3 found to have a high degree of matching. The epitope, epitope sequence, epitope location within HIV-1 MN gp160, and the sequence match between the samples is given in the table.